Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PER2 Antibody - middle region | Login | PER2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
TUT1 Antibody - middle region | Login | TUT1 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
BCL11A Antibody - C-terminal region | Login | BCL11A Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
Foxl2 Antibody - C-terminal region | Login | Foxl2 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
EBF1 Antibody | Login | EBF1 Antibody | ||||||||||||||||
|
||||||||||||||||||
HMBOX1 Antibody - N-terminal region | Login | HMBOX1 Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
LDLRAD2 Antibody - middle region | Login | LDLRAD2 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
LRP1 Antibody | Login | LRP1 Antibody | ||||||||||||||||
|
||||||||||||||||||
LTB Antibody - C-terminal region | Login | LTB Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
MAGEA1 Antibody - C-terminal region | Login | MAGEA1 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
MAK Antibody (Phospho-Tyr159) | Login | MAK Antibody (Phospho-Tyr159) | ||||||||||||||||
|
||||||||||||||||||
MAP2 Antibody | Login | MAP2 Antibody | ||||||||||||||||
|
||||||||||||||||||
MAP4 Antibody (Phospho-Ser696) | Login | MAP4 Antibody (Phospho-Ser696) | ||||||||||||||||
|
||||||||||||||||||
MAX Antibody (Phospho-Ser2) | Login | MAX Antibody (Phospho-Ser2) | ||||||||||||||||
|
||||||||||||||||||
MC1R Antibody - C-terminal region | Login | MC1R Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
MC2R Antibody - C-terminal region | Login | MC2R Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
MCM4 Antibody (Phospho-Ser54) | Login | MCM4 Antibody (Phospho-Ser54) | ||||||||||||||||
|
||||||||||||||||||
MDM4 Antibody (Phospho-Ser367) | Login | MDM4 Antibody (Phospho-Ser367) | ||||||||||||||||
|
||||||||||||||||||
MDM4 Antibody | Login | MDM4 Antibody | ||||||||||||||||
|
||||||||||||||||||
SCGB2A1 Antibody - N-terminal region | Login | SCGB2A1 Antibody - N-terminal region | ||||||||||||||||
|
||||||||||||||||||
MKI67 Antibody | Login | MKI67 Antibody | ||||||||||||||||
|
||||||||||||||||||
GRM8 Antibody - C-terminal region | Login | GRM8 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
CCL4L1 Antibody - middle region | Login | CCL4L1 Antibody - middle region | ||||||||||||||||
|
||||||||||||||||||
LMO3 Antibody - C-terminal region | Login | LMO3 Antibody - C-terminal region | ||||||||||||||||
|
||||||||||||||||||
MET Antibody (Phospho-Tyr1356) | Login | MET Antibody (Phospho-Tyr1356) | ||||||||||||||||
|